Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eplerenone--a novel selective aldosterone blocker.

Alan J Zillich1, Barry L Carter

  • 1Division of Clinical and Administrative Pharmacy and Department of Family Medicine, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA. alan.zillich@uiowa.edu

The Annals of Pharmacotherapy
|September 24, 2002
PubMed
Summary

Eplerenone, a novel selective aldosterone blocker, shows promise for treating hypertension and heart failure. Clinical trials indicate effectiveness with fewer adverse effects than spironolactone, suggesting a favorable safety profile.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Documentation of high blood pressure measurements in the emergency department: factors associated with discussion and comparison to other settings.

Internal and emergency medicine·2026
Same author

Intra-rater reliability of in-person versus simulated remote synchronous faculty evaluation of pharmacy student objective structured clinical examinations.

Currents in pharmacy teaching & learning·2025
Same author

Association of documented high blood pressure measurements with time to hypertension diagnosis.

The American journal of medicine·2025
Same author

Long-term opioid therapy in older adults: Incidence and risk factors related to patient characteristics and initial opioid dispensed.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes.

American journal of hypertension·2024

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiovascular Medicine

Background:

  • Aldosterone has detrimental effects in chronic conditions like hypertension and heart failure.
  • Selective aldosterone blockers represent a new therapeutic class.

Purpose of the Study:

  • To review the pharmacology, pharmacokinetics, clinical efficacy, and safety of eplerenone.
  • To assess the role of aldosterone antagonism in cardiovascular diseases.

Main Methods:

  • Comprehensive literature search of primary and review articles (MEDLINE, 1966-April 2002).
  • Inclusion of studies on eplerenone, aldosterone, aldosterone antagonists, and spironolactone.

Main Results:

  • Eplerenone demonstrates efficacy in hypertension treatment.

Related Experiment Videos

  • Animal studies suggest benefits in hypertension, heart failure, myocardial infarction, renal disease, and atherosclerosis.
  • Eplerenone shows a slightly lower incidence of adverse effects compared to spironolactone.

    • Conclusions:

    • Eplerenone is a promising selective aldosterone blocker.
    • Potential approval for hypertension treatment in 2002.
    • Ongoing studies may reveal additional clinical applications.